Skip to main content
. 2023 Jun 14;11(1):15. doi: 10.1007/s40203-023-00152-6

Table 5.

ADMET profile of hit compounds and reference drug

ADMET parameters Capivasertib Cynaroside Epicatechin gallate
hERG Inhibition 0.538 0.027 0.041
FDAMDD 0.922 0.031 0.55
Lipinski rule Accepted Rejected Accepted
Pfizer rule Accepted Accepted Accepted
GSK rule Rejected Rejected Rejected
Golden triangle rule Accepted Accepted Accepted
BBB 0.687 0.061 0.008
SAscore 3.256 3.924 3.608
CL 4.668 4.318 17.814
P-gp inhibitor 0.01 0.001 0.024
Bioavailability 0.55 0.17 0.55
Carcinogenicity 0.233 0.569 0.042
Nephrotoxicity 0.517 0.081 0.196